Tilly's Stock Price, News & Analysis (NYSE:TLYS)

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilly's in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" TLYS shares.
View TLYS analyst ratings or view top-rated stocks.

2 brokerages have issued 12 month price objectives for Tilly's' stock. Their TLYS share price targets range from $10.50 to $10.50. On average, they predict the company's share price to reach $10.50 in the next year. This suggests a possible upside of 21.4% from the stock's current price.
View analysts price targets for TLYS or view top-rated stocks among Wall Street analysts.

Tilly's' stock was trading at $9.05 at the start of the year. Since then, TLYS shares have decreased by 4.4% and is now trading at $8.65.
View the best growth stocks for 2023 here.

Tilly's saw a decrease in short interest in November. As of November 15th, there was short interest totaling 531,000 shares, a decrease of 25.5% from the October 31st total of 713,200 shares. Based on an average trading volume of 93,600 shares, the short-interest ratio is presently 5.7 days. Currently, 2.4% of the company's shares are short sold.
View Tilly's' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 30th 2023.
View our TLYS earnings forecast.

Tilly's will be holding an earnings conference call on Thursday, November 30th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "10183514".

Tilly's, Inc. (NYSE:TLYS) announced its earnings results on Thursday, August, 31st. The specialty retailer reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.17. The specialty retailer earned $159.95 million during the quarter, compared to analysts' expectations of $150.91 million. Tilly's had a negative trailing twelve-month return on equity of 4.47% and a negative net margin of 1.19%. During the same quarter in the previous year, the firm posted $0.13 EPS.

Tilly's updated its third quarter 2023 earnings guidance on Friday, September, 1st. The company provided earnings per share (EPS) guidance of -$0.11--$0.05 for the period, compared to the consensus estimate of -$0.07. The company issued revenue guidance of $166.00 million-$171.00 million, compared to the consensus revenue estimate of $161.90 million.

97 employees have rated Tilly's Chief Executive Officer Edmond Thomas on Glassdoor.com. Edmond Thomas has an approval rating of 71% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilly's investors own include Pennsylvania Real Estate Investment Trust (PEI), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), KushCo (KSHB), Organigram (OGI), Zosano Pharma (ZSAN), DHT (DHT), EnLink Midstream (ENLC) and Washington Prime Group (WPG).

Tilly's' stock is owned by a variety of retail and institutional investors. Top institutional investors include Newtyn Management LLC (2.21%), Pacific Ridge Capital Partners LLC (2.14%), First Eagle Investment Management LLC (1.17%), Northern Trust Corp (0.60%), Jacobs Levy Equity Management Inc. (0.51%) and Bank of New York Mellon Corp (0.44%). Insiders that own company stock include Bernard Zeichner, Edmond Thomas, Fund 1 Investments, Llc, Hezy Shaked, Janet Kerr, Jonathon David Kosoff, Marc Nissan, Michael Henry, Robert Simon Goodwin and Tricia D Smith.
View institutional ownership trends.

Shares of TLYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.